Optinose Reports First Quarter 2020 Financial Results and Operational Updates
Company reports first quarter 2020 XHANCE net revenue of $7.1 million First quarter 2020 XHANCE prescriptions increased 149% from first quarter 2019 Conference call and webcast to be held today at 4:15 p.m. Eastern Time YARDLEY, Pa., May 07, 2020 (GLOBE …